1. Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment
- Author
-
Zoann Nugent, Cheryl Peltier, Aaron J. Marshall, Carly McFall, Donna Hewitt, Edgard M. Mejia, Paul Fernyhough, Linda Davidson, Christine A. Doucette, David E. Dawe, Grant M. Hatch, Eric D.J. Bouchard, Spencer B. Gibson, Garry X. Shen, Sen Hou, Versha Banerji, Mandy Squires, Ryan Saleh, Subir K. Roy Chowdhury, and James B. Johnston
- Subjects
0301 basic medicine ,Cancer Research ,ZAP-70 ,Chronic lymphocytic leukemia ,B-cell receptor ,CCL3/CCL4 ,Mitochondrion ,CD38 ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,immune system diseases ,ibrutinib ,hemic and lymphatic diseases ,Respiration ,medicine ,Bruton's tyrosine kinase ,biology ,B cell receptor ,breakpoint cluster region ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,mitochondria ,030104 developmental biology ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Ibrutinib ,oxygen consumption rates ,Cancer research ,biology.protein ,chronic lymphocytic leukemia ,Oroboros oxygraph - Abstract
Mitochondrial bioenergetics profiling, a measure of oxygen consumption rates, correlates with prognostic markers and can be used to assess response to therapy in chronic lymphocytic leukemia (CLL) cells. In this study, we measured mitochondrial respiration rates in primary CLL cells using respirometry to evaluate mitochondrial function. We found significant increases in mitochondrial respiration rates in CLL versus control B lymphocytes. We also observed amongst CLL patients that advanced age, female sex, zeta-chain-associated protein of 70 kD (ZAP-70+), cluster of differentiation 38 (CD38+), and elevated &beta, 2-microglobulin (&beta, 2-M) predicted increased maximal respiration rates. ZAP-70+ CLL cells exhibited significantly higher bioenergetics than B lymphocytes or ZAP-70- CLL cells and were more sensitive to the uncoupler, carbonyl cyanide-p-trifluoro-methoxyphenylhydrazone (FCCP). Univariable and multivariable linear regression analysis demonstrated that ZAP-70+ predicted increased maximal respiration. ZAP-70+ is a surrogate for B cell receptor (BCR) activation and can be targeted by ibrutinib, which is a clinically approved Bruton&rsquo, s tyrosine kinase (BTK) inhibitor. Therefore, we evaluated the oxygen consumption rates (OCR) of CLL cells and plasma chemokine (C-C motif) ligands 3 and 4 (CCL3/CCL4) levels from ibrutinib-treated patients and demonstrated decreased OCR similar to control B lymphocytes, suggesting that ibrutinib treatment resets the mitochondrial bioenergetics, while diminished CCL3/CCL4 levels indicate the down regulation of the BCR signaling pathway in CLL. Our data support evaluation of mitochondrial respiration as a preclinical tool for the response assessment of CLL cells.
- Published
- 2020
- Full Text
- View/download PDF